About this trial
In the context of the COLORIZE study, it is being tested whether the endoscopic light mode Texture and Color Enhancement Imaging (TXI) is non-inferior to the standard White Light Endoscopy (WLE) in assessing inflammatory activity in patients with Inflammatory Bowel Disease (IBD). For this purpose, ileocolonoscopy is performed on patients diagnosed with IBD, and standardized image documentation will be carried out in both WLE and TXI modes. Step biopsies are taken, and clinically validated, endoscopic, and histological scores are used.
Eligibility criteria
Qualifiers
Histologically confirmed inflammatory bowel disease (ulcerative colitis or Crohn's disease)
Age ≥ 18 years
Disqualifiers
Post (procto-) colectomy
Endoscopically impassable stenosis in the left hemi-colon
ASA status > 2 points
BBPS < 6 points (or < 2 points per segment)
Trial design
Treatments tested in this trial
- TXI mode vs. WLE mode